Valuation : Kenvue Inc.

Market Cap 36B 30.96B 29.12B 26.58B 49.71B 3,404B 49.87B 345B 133B 1,743B 135B 132B 5,553B P/E 2026 *
19.7x
P/E 2027 * 17.1x
Enterprise Value 43.09B 37.06B 34.86B 31.82B 59.51B 4,075B 59.7B 413B 160B 2,087B 162B 158B 6,648B EV / Sales 2026 *
2.76x
EV / Sales 2027 * 2.66x
Free-Float
98.88%
Yield 2026 *
4.5%
Yield 2027 * 4.6%
1 day-1.11%
1 week-2.24%
Current month-0.74%
1 month-2.29%
3 months+5.82%
6 months+1.90%
Current year+8.64%
1 week 18.69
Extreme 18.69
19.18
1 month 18.65
Extreme 18.65
19.56
Current year 16.56
Extreme 16.555
20.13
1 year 14.02
Extreme 14.02
20.13
3 years 14.02
Extreme 14.02
25.17
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
Manager TitleAgeSince
Chief Executive Officer 56 2025-07-13
Director of Finance/CFO 48 2026-05-11
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 2023-04-30
Director/Board Member 66 2023-05-03
Director/Board Member 59 2023-05-07
Date Insider Type Main position Quantity % Market Cap. Importance
7/31/26 Exercice

Executive/Senior Manager

32,838 0.0017%
5/21/26 Free

Director

10,309 0.0005%
5/21/26 Free

Chairman

16,036 0.0008%
Change 5-day change 1-year change 3-year change Capi.($)
-1.11%-2.24%+0.64%-16.26% 36B
-0.33%+1.85%-8.49%-3.75% 340B
-1.46%-1.73%-12.52%+4.78% 139B
-1.47%-2.18%+4.28%+22.75% 70.77B
-0.68%-2.51%-25.57%-22.33% 49.11B
+2.97%+0.45%+16.43%-33.67% 37.58B
-0.81%-5.90%-0.52%+21.66% 20.26B
-1.10%-5.99%-22.32%-37.34% 19.37B
-1.36%-4.18%+4.19%+8.48% 19.28B
-1.83%-5.80%-30.01%-14.82% 9.52B
Average -0.72%-1.94%-7.39%-7.05% 74.07B
Weighted average by Cap. -0.62%+0.03%-7.54%-2.98%

Financials

2026 *2027 *
Net sales 15.6B 13.41B 12.61B 11.52B 21.54B 1,475B 21.61B 150B 57.81B 755B 58.57B 57.29B 2,406B 15.97B 13.73B 12.91B 11.79B 22.05B 1,510B 22.12B 153B 59.19B 773B 59.96B 58.65B 2,463B
Net income 1.83B 1.57B 1.48B 1.35B 2.53B 173B 2.54B 17.55B 6.78B 88.63B 6.87B 6.72B 282B 2.11B 1.82B 1.71B 1.56B 2.92B 200B 2.93B 20.26B 7.83B 102B 7.93B 7.76B 326B
Net Debt 7.1B 6.1B 5.74B 5.24B 9.8B 671B 9.83B 68.06B 26.31B 344B 26.65B 26.07B 1,095B 6.52B 5.61B 5.27B 4.81B 9B 617B 9.03B 62.53B 24.17B 316B 24.48B 23.95B 1,006B
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
21,890
Date Price Change Volume
26-09-04 US$18.74 -1.11% 26,856,871
26-09-03 US$18.95 -0.94% 18,570,436
26-09-02 US$19.13 +2.03% 19,692,893
26-09-01 US$18.75 -0.69% 21,754,679
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.74USD
Average target price
19.50USD
Spread / Average Target
+4.06%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KVUE Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!